Maynard Um
-
-
-
-
-
-
-
Raymond James sees a 'unique buying opportunity' in this stock
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
-
-
-
-
-
-
-
Praxis Precision Medicines receives FDA acceptance for essential tremor drug
-
-
-
-
-
-
-
Truist on Praxis Precision Medicines Inc. (PRAX): 'We see Significant Upside Potential To Our Base Case'
-
-
-
-
-
-
-
Praxis Precision Medicines hires epilepsy expert Dr. Orrin Devinsky as head of clinical strategy
-
-
-
-
-
-
-
Truist Reiterates 'High Conviction' Buy Rating on Praxis Precision Medicines Inc. (PRAX)
-
-
-
-
-
-
-
Praxis Precision Medicines Inc. (PRAX) PT Raised to $750 (from $250) at Oppenheimer
-
433,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

